Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07449208 · ClinicalTrials.gov registry record
Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak
A clinical trial of Anastomotic Leak and Esophageal Malignant Neoplasm Primary, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 7
- Study locations
NCT07449208: Recruiting study of Anastomotic Leak and Esophageal Malignant Neoplasm Primary, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07449208 is a study of Anastomotic Leak and Esophageal Malignant Neoplasm Primary that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 40 participants, below the 119-participant average among 3 other Anastomotic Leak trials with a reported enrollment target (66% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07449208, a study of Anastomotic Leak and Esophageal Malignant Neoplasm Primary, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 7
- Study locations
Study Summary
The main purpose of this study is to look at how often anastomotic leaks happen in participants who are at high risk of these leaks and are eligible to receive gastric preconditioning by percutaneous angioembolization before an esophagectomy.
Primary Outcome
Determine the incidence of anastomotic leak among participants with a high risk of esophageal leak who undergo esophagectomy after preoperative gastric preconditioning by percutaneous angioembolization.
Conditions Studied
Interventions
- PROCEDURE Esophagectomy
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All protocol activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (All Protocol Activities) - Rockville Centre
New Jersey
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-02-25 |
| Est. Completion | 2029-02-25 |
What NCT07449208 shows while recruiting
NCT07449208 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 119-participant average among 3 other Anastomotic Leak trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Anastomotic Leak appearing as the primary indexed condition, and to 1 intervention - of which Esophagectomy is the first listed.
NCT07449208 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT07449208 about?
NCT07449208 is a clinical study titled "Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak". The main purpose of this study is to look at how often anastomotic leaks happen in participants who are at high risk of these leaks and are eligible to receive gastric preconditioning by percutaneous angioembolization before an esophagectomy.
What is the current status of trial NCT07449208?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2026-02-25. Estimated completion is 2029-02-25.
What conditions does trial NCT07449208 study?
This clinical trial studies the following conditions: Anastomotic Leak, Esophageal Malignant Neoplasm Primary.
What interventions are being tested in trial NCT07449208?
The interventions under investigation include: Esophagectomy (PROCEDURE).
Who is sponsoring clinical trial NCT07449208?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07449208 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anastomotic Leak
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
RECRUITING · NA
-
A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection
RECRUITING · NA
-
A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI